Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Reply to “Comment on ‘Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients with Hemophilia A in China: Discrete Choice Experiment Study’ ”from Li et al.
Limin Wang;
Shimeng Liu;
Shan Jiang;
Chaofan Li;
Liyong Lu;
Yunhai Fang;
Shunping Li
International Registered Report:
RR2-10.2196/45747
Citation
Please cite as:
Wang L, Liu S, Jiang S, Li C, Lu L, Fang Y, Li S
Authors’ Reply: “The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies”